The current landscape of pharmaceutical marketing is undergoing a profound transformation as the
Physics-based simulations of how X-rays interact with human tissue density allow the xvr system to
Maternal health and newborn outcomes show no significant differences between those who use non-invasive genetic screening and those who rely on conventional grading. This finding emerges from a pivotal moment in reproductive medicine, where the promise of sophisticated genomic tools often outpaces
Vascularization remains a critical biotechnological hurdle for the industry, as thick tissue cuts cannot survive without internal systems to deliver nutrients and remove waste. This fundamental challenge defines the current landscape of cellular agriculture in 2026, as scientists move beyond basic
The current pharmaceutical landscape is witnessing a profound transformation as the successful
CordenPharma is proactively responding to the evolving healthcare landscape by enhancing its
The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at nearly any cost, the industry now faces a harder test: turning that science into scalable,…
The partnership between Eli Lilly and NVIDIA to build a supercomputer capable of running trillions
In 2026, boards and customers are asking a direct question: can promising science be turned into
The pharmaceutical sector is entering a decisive phase as obesity therapeutics gain more ground as
Advanced Therapy Medicinal Products cannot be scaled the same way biologics were. The core
Before a patient even enters the room, Tandem Health’s AI synthesizes complex medical histories into concise summaries to streamline the clinical consultation process. This innovative approach has paved the way for the Stockholm-based company to secure a landmark $100 million Series B funding
Reliability and standardization are the new metrics of success as the industry attempts to ensure
Autonomous laboratories are reducing the cost of innovation by allowing researchers to explore
